QA: Oncotelic Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000908259_2022_Oncotelic_Therapeutics_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000908259')"}

Graph

Absolute values for 0000908259, Oncotelic Therapeutics Inc.

  xvar xval
0 AssetsCurrent 627,295
1 IntangibleAssetsNetIncludingGoodwill 21,884,296
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,101,760
4 LiabilitiesCurrent 15,454,920
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,467,266
9 ResearchAndDevelopmentExpense 3,658,617
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,391,407
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,613,351
1 Liabilities 15,454,920
2 Expenses 9,125,883
3 Revenues 0
4 StockholdersEquity 8,158,431
5 NetIncome -10,517,290
6 ComprehensiveNetIncome -10,517,290
7 BaseVar 24,792,780
8 EconomicCapitalRatio 0.180

Edgar->Model Mapping

Feature Distribution

Change over Time